DAFNA Capital Management as of Dec. 31, 2018
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 83 positions in its portfolio as reported in the December 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Loxo Oncology | 12.7 | $25M | 182k | 140.07 | |
Stereotaxis (STXS) | 7.3 | $15M | 14M | 1.08 | |
Sage Therapeutics (SAGE) | 5.0 | $10M | 104k | 95.79 | |
AtriCure (ATRC) | 4.8 | $9.8M | 319k | 30.60 | |
NxStage Medical | 4.4 | $8.9M | 312k | 28.62 | |
iShares NASDAQ Biotechnology Index (IBB) | 3.1 | $6.3M | 65k | 96.43 | |
Argenx Se (ARGX) | 2.8 | $5.6M | 58k | 96.07 | |
Zogenix | 2.6 | $5.2M | 144k | 36.46 | |
Aerie Pharmaceuticals | 2.5 | $5.1M | 142k | 36.10 | |
Blueprint Medicines (BPMC) | 2.5 | $5.0M | 93k | 53.91 | |
Ascendis Pharma A S (ASND) | 2.4 | $4.8M | 77k | 62.65 | |
Proqr Thrapeutics N V shs euro (PRQR) | 2.1 | $4.3M | 273k | 15.78 | |
Dex (DXCM) | 2.0 | $4.1M | 34k | 119.79 | |
Alder Biopharmaceuticals | 2.0 | $4.1M | 396k | 10.25 | |
Akebia Therapeutics (AKBA) | 2.0 | $4.0M | 716k | 5.53 | |
Neurocrine Biosciences (NBIX) | 1.9 | $3.9M | 55k | 71.41 | |
Galapagos Nv- (GLPG) | 1.9 | $3.8M | 42k | 91.73 | |
BioCryst Pharmaceuticals (BCRX) | 1.9 | $3.7M | 464k | 8.07 | |
Arena Pharmaceuticals | 1.8 | $3.7M | 94k | 38.95 | |
Intec Pharma | 1.7 | $3.5M | 463k | 7.54 | |
Luminex Corporation | 1.6 | $3.2M | 138k | 23.11 | |
Radius Health Inc note 3.000% 9/0 | 1.5 | $3.1M | 4.0M | 0.77 | |
Biohaven Pharmaceutical Holding | 1.5 | $3.0M | 80k | 36.98 | |
Foamix Pharmaceuticals | 1.4 | $2.9M | 808k | 3.59 | |
Bluebird Bio (BLUE) | 1.3 | $2.7M | 27k | 99.19 | |
Cymabay Therapeutics | 1.3 | $2.6M | 333k | 7.87 | |
Biotelemetry | 1.3 | $2.6M | 43k | 59.72 | |
Menlo Therapeutics | 1.1 | $2.2M | 541k | 4.12 | |
Kura Oncology (KURA) | 1.0 | $2.1M | 149k | 14.04 | |
Wave Life Sciences (WVE) | 1.0 | $2.0M | 48k | 42.05 | |
Cardiovascular Systems | 0.9 | $1.9M | 66k | 28.49 | |
Cara Therapeutics (CARA) | 0.9 | $1.9M | 144k | 13.00 | |
Translate Bio | 0.8 | $1.7M | 229k | 7.50 | |
Insulet Corp note 1.375% | 0.8 | $1.6M | 1.5M | 1.06 | |
Xenon Pharmaceuticals (XENE) | 0.8 | $1.5M | 238k | 6.31 | |
Incyte Corporation (INCY) | 0.7 | $1.4M | 22k | 63.58 | |
Viking Therapeutics (VKTX) | 0.7 | $1.4M | 179k | 7.65 | |
Vbi Vaccines | 0.7 | $1.4M | 850k | 1.60 | |
Concert Pharmaceuticals I equity | 0.7 | $1.3M | 106k | 12.55 | |
Natus Medical | 0.6 | $1.3M | 38k | 34.04 | |
ArQule | 0.6 | $1.3M | 458k | 2.77 | |
Dicerna Pharmaceuticals | 0.6 | $1.3M | 119k | 10.69 | |
Johnson & Johnson (JNJ) | 0.6 | $1.2M | 9.4k | 129.04 | |
Nevro (NVRO) | 0.6 | $1.2M | 31k | 38.90 | |
Immunomedics | 0.6 | $1.2M | 82k | 14.27 | |
Cytokinetics (CYTK) | 0.6 | $1.2M | 186k | 6.32 | |
Assembly Biosciences | 0.6 | $1.1M | 51k | 22.62 | |
Achillion Pharmaceuticals | 0.5 | $1.0M | 630k | 1.59 | |
Macrogenics (MGNX) | 0.5 | $994k | 78k | 12.69 | |
Arbutus Biopharma (ABUS) | 0.5 | $946k | 247k | 3.83 | |
Corbus Pharmaceuticals Hldgs | 0.5 | $905k | 155k | 5.84 | |
Applied Genetic Technol Corp C | 0.4 | $894k | 359k | 2.49 | |
Ardelyx (ARDX) | 0.4 | $846k | 473k | 1.79 | |
Madrigal Pharmaceuticals (MDGL) | 0.4 | $744k | 6.6k | 112.73 | |
Urogen Pharma (URGN) | 0.3 | $646k | 15k | 43.07 | |
Scynexis | 0.3 | $611k | 1.3M | 0.48 | |
Obseva Sa | 0.3 | $561k | 44k | 12.65 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.2 | $500k | 213k | 2.35 | |
Valeritas Hldgs | 0.2 | $437k | 1.3M | 0.33 | |
Aldeyra Therapeutics (ALDX) | 0.2 | $415k | 50k | 8.30 | |
Spero Therapeutics (SPRO) | 0.2 | $431k | 70k | 6.16 | |
Kalvista Pharmaceuticals (KALV) | 0.2 | $399k | 20k | 19.73 | |
Zafgen | 0.2 | $358k | 72k | 4.95 | |
Radius Health | 0.2 | $338k | 21k | 16.49 | |
Leap Therapeutics | 0.2 | $340k | 170k | 2.00 | |
Dexcom Inc dbcv 0.750% 5/1 | 0.2 | $335k | 250k | 1.34 | |
Rigel Pharmaceuticals (RIGL) | 0.2 | $317k | 138k | 2.30 | |
Masimo Corporation (MASI) | 0.2 | $322k | 3.0k | 107.33 | |
Advaxis | 0.2 | $317k | 1.7M | 0.19 | |
Arcturus Therapeutics | 0.2 | $330k | 73k | 4.53 | |
Phasebio Pharmaceuticals (PHASQ) | 0.1 | $309k | 100k | 3.09 | |
Sutro Biopharma (STRO) | 0.1 | $284k | 32k | 9.02 | |
Aptinyx | 0.1 | $240k | 15k | 16.55 | |
Alder Biopharmaceuticals Inc convertible security | 0.1 | $200k | 250k | 0.80 | |
Sol Gel Technologies (SLGL) | 0.1 | $211k | 35k | 6.03 | |
Minerva Neurosciences | 0.1 | $176k | 26k | 6.75 | |
Proteostasis Therapeutics In | 0.1 | $177k | 55k | 3.24 | |
Kadmon Hldgs | 0.1 | $136k | 66k | 2.08 | |
BioTime | 0.1 | $91k | 100k | 0.91 | |
Bellicum Pharma | 0.0 | $88k | 30k | 2.93 | |
Dermira | 0.0 | $72k | 10k | 7.20 | |
Oramed Pharm (ORMP) | 0.0 | $48k | 16k | 3.00 | |
Neos Therapeutics | 0.0 | $45k | 28k | 1.64 |